Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $1.78 in the prior trading day, Pliant Therapeutics Inc (NASDAQ: PLRX) closed at $1.74, down -2.25%. In other words, the price has decreased by -$2.25 from its previous closing price. On the day, 0.58 million shares were traded. PLRX stock price reached its highest trading level at $1.805 during the session, while it also had its lowest trading level at $1.71.
Ratios:
Our goal is to gain a better understanding of PLRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.99 and its Current Ratio is at 12.99. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.27.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 17 ’25 when Coulie Bernard sold 52,419 shares for $11.20 per share. The transaction valued at 587,150 led to the insider holds 430,517 shares of the business.
Cummings Keith Lamont sold 20,148 shares of PLRX for $225,680 on Jan 17 ’25. The Chief Financial Officer now owns 262,608 shares after completing the transaction at $11.20 per share. On Jan 17 ’25, another insider, Hull Hans, who serves as the Chief Business Officer of the company, sold 15,936 shares for $11.20 each. As a result, the insider received 178,501 and left with 211,558 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLRX now has a Market Capitalization of 106815384 and an Enterprise Value of -95681616.
Stock Price History:
The Beta on a monthly basis for PLRX is 1.44, which has changed by -0.87633264 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, PLRX has reached a high of $16.10, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 9.52%, while the 200-Day Moving Average is calculated to be -29.52%.
Shares Statistics:
The stock has traded on average 852.77K shares per day over the past 3-months and 1255020 shares per day over the last 10 days, according to various share statistics. A total of 61.39M shares are outstanding, with a floating share count of 54.04M. Insiders hold about 11.97% of the company’s shares, while institutions hold 82.37% stake in the company. Shares short for PLRX as of 1760486400 were 3827992 with a Short Ratio of 4.49, compared to 1757894400 on 3737575. Therefore, it implies a Short% of Shares Outstanding of 3827992 and a Short% of Float of 6.39.
Earnings Estimates
The firm’s stock currently is rated by 8.0 analysts. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.11 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$2.26 and -$5.23 for the fiscal current year, implying an average EPS of -$2.86. EPS for the following year is -$2.59, with 9.0 analysts recommending between -$1.48 and -$6.64.
